Faulding Zinc

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ixtrih issa

Ingredjent attiv:

selenomethionine, Quantity: 65 microgram (Equivalent: selenium, Qty 26 microgram); zinc amino acid chelate, Quantity: 100 mg (Equivalent: zinc, Qty 20 mg); pyridoxine hydrochloride, Quantity: 20 mg (Equivalent: pyridoxine, Qty 16.45 mg); zinc sulfate monohydrate, Quantity: 68.7 mg (Equivalent: zinc, Qty 25 mg)

Disponibbli minn:

Symbion Pty Ltd

INN (Isem Internazzjonali):

pyridoxine hydrochloride,Selenomethionine,zinc amino acid chelate,Zinc sulfate monohydrate

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: polyvinyl alcohol; colloidal anhydrous silica; povidone; crospovidone; macrogol 4000; microcrystalline cellulose; titanium dioxide; macrogol 3350; calcium hydrogen phosphate dihydrate; magnesium stearate; purified talc; lecithin; hypromellose

Rotta amministrattiva:

Oral

Indikazzjonijiet terapewtiċi:

Antioxidant/Reduce free radicals formed in the body ; Maintain/support general health and wellbeing ; Maintain/support immune system health ; Maintain/support healthy immune system function ; Maintain/support (state vitamin/mineral/nutrient) levels in the body ; Helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; Maintain/support healthy reproductive hormones ; Maintain/support skin health

Sommarju tal-prodott:

Visual Identification: ;

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2014-02-07

Ara l-istorja tad-dokumenti